tiprankstipranks
Trending News
More News >

Joseph E Payne Insider Profile

4 Followers
Joseph E Payne, President & CEO, Director at Arcturus Therapeutics, holds 1.48M shares in Arcturus Therapeutics (Ticker: ARCT), holds 861.25K shares in GRI Bio (Ticker: GRI). Most recently, Joseph E Payne Bought ― shares of Arcturus Therapeutics on Nov 28, 2022 for an estimated value of 82.55K.
tipranks
Joseph E Payne

Joseph E Payne
Arcturus Therapeutics (ARCT)
President & CEO, Director

Ranked #6,001 out of 100,956 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+86.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$27M
79.22%
20.78%
A breakdown of Joseph E Payne's holdings

Insider Roles

Arcturus Therapeutics
(ARCT)
President & CEO, Director
GRI Bio
(GRI)
Director
Roles that Joseph E Payne holds in companies

Most Profitable Insider Trade

Stock:
Arcturus Therapeutics
(ARCT)
Rating:Informative Buy
Date:Aug 30, 2019 - Aug 30, 2020
Return:+365.60%
The most profitable trade made by Joseph E Payne

Joseph E Payne's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Arcturus Therapeutics
Nov 28, 2022
President & CEO, Director
Informative Buy
82.55K
$21.54M
GRI Bio
May 27, 2021
Director
Informative Buy
71.80K
$5.65M
List of latest transactions for each holding click on a transaction to see Joseph E Payne's performance on stock

Joseph E Payne insider profile FAQ

What is the percentage of profitable transactions made by Joseph E Payne?
The percentage of profitable transactions made by Joseph E Payne is 75%.
    What is the average return per transaction made by Joseph E Payne?
    The average return per transaction made by Joseph E Payne is 86.00%.
      What stocks does Joseph E Payne hold?
      Joseph E Payne holds: ARCT, GRI stocks.
        What was Joseph E Payne’s latest transaction?
        Joseph E Payne latest transaction was an Informative Buy of $82.55K.
          What was Joseph E Payne's most profitable transaction?
          Joseph E Payne’s most profitable transaction was an Informative Buy of ARCT stock on August 30, 2019. The return on the trade was 365.60%.
            What is Joseph E Payne's role in Arcturus Therapeutics?
            Joseph E Payne's role in Arcturus Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.